Table 1.

Demographics, clinical characteristics, and results of BoNT therapy.

Age (years) [mean ± SD]	54.5 ± 9.1
Sex, (n [%])	Women Men NR	669 (60.3) 413 (37.4) 21 (1.9)
Etiology, (n [%])	Idiopathic Tardive Acquired NR	650 (58.9) 272 (24.7) 138 (12.5) 72 (6.5)
Subtype of OMD, (n [%])	Jaw closing dystonia Tongue dystonia Jaw opening dystonia Mixed dystonia Jaw deviation dystonia Jaw protrusion dystonia Lip dystonia Perioral dystonia NR	438 (39.7) 252 (22.8) 193 (17.5) 74 (6.7) 46 (4.2) 18 (1.6) 13 (1.2) 1 (0.1) 88 (8)
Other dystonia, (n [%])	Cervical dystonia Blepharospasm Limb dystonia Spasmodic dysphonia Writer‘s cramp Generalized dystonia Embouchure dystonia Other NR	181 (16.4) 153 (13.9) 43 (3.9) 27 (2.4) 15 (1.4) 10 (0.9) 3 (0.3) 2 (0.2) 208 (18.9)
Number of injections (times) [mean ± SD]	4.1 ± 2.8
Muscles injected, (n [%])	Masseter Lateral pterygoid Genioglossus Temporalis Submentalis Medial pterygoid Anterior digastric Posterior digastric Orbicularis oris Risorius Mentalis Platysma Sternocleidomastoid Other NR	537 (48.7) 278 (25.2) 258 (23.4) 210 (19) 186 (16.9) 60 (5.4) 47 (4.3) 30 (2.7) 29 (2.6) 17 (1.5) 15 (1.4) 14 (1.3) 12 (1.1) 46 (4.2) 31 (2.8)
Dose (units) [mean ± SD]	Masseter Lateral pterygoid Genioglossus Temporalis Submentalis Medial pterygoid Anterior digastric Posterior digastric Platysma	43.8 (35.7) 37.1 (48.9) 22.2 (12.6) 26.2 (14.3) 23.8 (9.2) 19 (5.7) 17.1 (7.9) 8.9 (4.6) 12.3 (6.7)
Adverse events, (n [%])	Dysphagia Dysarthria Pain Chewing difficulty Lip numbness Swelling None Other	111 (10.1) 10 (0.9) 9 (0.8) 5 (0.5) 5 (0.5) 2 (0.2) 881 (79.9) 37 (3.4)

OMD, oromandibular dystonia; NR, not reported.